Header Ads Widget

Ticker

6/recent/ticker-posts

GIROUD ON THE ‘VERGE OF SIGNING TWO-YEAR DEAL WITH ITALIAN OUTFIT AC MILAN’

Chelsea striker Olivier Giroud is on the verge of signing a two-year contract with Italian outfit AC Milan, according to reports.



AC Milan has hoped to sign the World Cup winner on a free transfer this summer when his contract expired. However, Chelsea activated their option to extend his deal by one more season.

As a result, Milan will be forced to pay the striker’s £1million release clause on top of his £3m salary in order to secure his signature for the 2021-2022 season.

Negotiations over the 34-year-old’s contract have been ongoing, but according to Football Italia, the two parties have reached an agreement.

The Italian outfit are set to pay out the strikers £1m release clause and his £3m salary. The fee is reportedly more than Rossoneri wanted to pay for the striker – who has struggled for pitch time since Thomas Tuchel’s arrival at Chelsea.

However, given Zlatan Ibrahimovic’s injury, Milan are eager to secure the signature of their primary transfer target.

Tiemoue Bakayoko is another player who is wanted by Milan and who is also eager to force a move away from Stamford Bridge.

Nevertheless, it won’t be simple task for Milan to acquire his services after the 26-year-old picked up interest from Ligue 1 outfit Nice this summer.

Bakayoko has, however, said that an ideal situation would see him sign for the Italian outfit.

The 26-year-old’s agent, previously spoke about Bakayoko’s future and the chances of a return to Milan.

‘Milan are looking for a player with his characteristics and it’s likely that they can make a proposal,’ he said to Calcio Mercato.

‘At the moment, Tiemoue is a Chelsea player, but there’s a possibility to change his shirt and go to an Italian team.

‘Milan are a great team and if the opportunity arises, we will do everything possible to bring him to the Rossoneri. [Paolo] Maldini and [Frederic] Massara know him, they know what he can give.’

Post a Comment

0 Comments